"Appetite Stimulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that are used to stimulate appetite. These drugs are frequently used to treat anorexia associated with cancer and AIDS.
| Descriptor ID |
D019167
|
| MeSH Number(s) |
D27.505.696.282.050 D27.505.954.427.220.050
|
| Concept/Terms |
Appetite Stimulants- Appetite Stimulants
- Stimulants, Appetite
- Appetite-Stimulating Drugs
- Appetite Stimulating Drugs
- Drugs, Appetite-Stimulating
|
Below are MeSH descriptors whose meaning is more general than "Appetite Stimulants".
Below are MeSH descriptors whose meaning is more specific than "Appetite Stimulants".
This graph shows the total number of publications written about "Appetite Stimulants" by people in this website by year, and whether "Appetite Stimulants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 1 | 1 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2022 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Appetite Stimulants" by people in Profiles.
-
Things We Do for No Reason?: Prescribing appetite stimulants to hospitalized older adults with unintentional weight loss. J Hosp Med. 2022 05; 17(5):389-392.
-
Intracranial Hypertension Induced by Megestrol Acetate Withdrawal. J Neuroophthalmol. 2019 03; 39(1):107-110.
-
The Evolving Approach to Management of Cancer Cachexia. Oncology (Williston Park). 2017 01 15; 31(1):23-32.
-
Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials. Lancet Oncol. 2015 Jan; 16(1):108-16.
-
Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options - a mini-review. Gerontology. 2014; 60(4):294-305.
-
Inhibition of cisplatin-induced lipid catabolism and weight loss by ghrelin in male mice. Endocrinology. 2013 Sep; 154(9):3118-29.
-
Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study. Support Care Cancer. 2013 Jan; 21(1):129-37.
-
Evaluation and pharmacologic management of symptoms in cancer patients undergoing acute rehabilitation in a comprehensive cancer center. Arch Phys Med Rehabil. 2007 Jul; 88(7):891-5.
-
Cannabinoids in supportive care: are they necessary? Support Care Cancer. 2003 Mar; 11(3):133-4.
-
Update on anorexia and cachexia. Hematol Oncol Clin North Am. 2002 Jun; 16(3):589-617.